Drug profile · INN
rauwolfia serpentina root
RAUWOLFIA SERPENTINA
rauwolfia serpentina root (RAUWOLFIA SERPENTINA) is a adrenergic receptor alpha antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — rauwolfia serpentina root
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
rauwolfia serpentina root (RAUWOLFIA SERPENTINA) is a adrenergic receptor alpha antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Adrenergic receptor alpha antagonist
Primary target: Adrenergic receptor alpha
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is rauwolfia serpentina root?
rauwolfia serpentina root (RAUWOLFIA SERPENTINA) is a adrenergic receptor alpha antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for rauwolfia serpentina root?
RAUWOLFIA SERPENTINA is a marketed brand name for rauwolfia serpentina root. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of rauwolfia serpentina root?
rauwolfia serpentina root has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.